Inventor · disambiguated record
Daniel J. Burdick
Also filed as: BURDICK DANIEL · BURDICK DANIEL J · BURDICK DANIEL JON
16 granted patents·4 pending applications·230 citations·filing 2001–2020
92Inventor score
Top patents by PatentIndex Score
20 records- 0194US9212173B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·18 cites·3 claims
- 0294US6667318B2LFA-1 antagonist compoundsGENENTECH INC·Filed 2001·Granted Dec 23, 2003·65 cites·21 claims
- 0393US8815882B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsBAKER-GLENN CHARLES·Filed 2011·Granted Aug 26, 2014·34 cites·22 claims
- 0493US8354420B2Aminopyrimidine derivatives as LRRK2 inhibitorsGENENTECH INC·Filed 2011·Granted Jan 15, 2013·27 cites·26 claims
- 0593US6872735B2LFA-1 antagonist compoundsGENENTECH INC·Filed 2003·Granted Mar 29, 2005·51 cites·21 claims
- 0688US8802674B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 12, 2014·12 cites·15 claims
- 0786US8809331B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 19, 2014·12 cites·5 claims
- 0883US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 0979US10183009B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jan 22, 2019·3 cites·22 claims
- 1078US10239861B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Mar 26, 2019·2 cites·7 claims
- 1168US10150767B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 11, 2018·1 cites·14 claims
- 1264US10787484B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2018·Granted Sep 29, 2020·0 cites·73 claims
- 1362US11034725B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2020·Granted Jun 15, 2021·0 cites·9 claims
- 1453US9382257B2Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitorsGENENTECH INC·Filed 2015·Granted Jul 5, 2016·0 cites·7 claims
- 1553US2005148588A1LFA-1 antagonist compoundsGENENTECH INC·Filed 2005·Application pending·0 cites
- 1648US2008318989A1Pyrimidine Kinase InhibitorsBURDICK DANIEL J·Filed 2006·Application pending·0 cites
- 1747US2010144732A1Pyrimidine kinase inhibitorsKRUEGER ELAINE B·Filed 2007·Application pending·0 cites
- 1843US2005203135A1Antagonists for treatment of CD/11CD18 adhesion receptor mediated disordersGENENTECH INC·Filed 2003·Application pending·0 cites
- 1940US10258603B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Apr 16, 2019·0 cites·15 claims
- 2040US10202378B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 12, 2019·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →